相关实验视频

Updated: May 8, 2025

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays

Published on: February 24, 2023

从治疗到癌症预防,使用HRD测试对高级卵巢癌患者进行HRD测试

Maria Grazia Tibiletti¹, Ileana Carnevali², Sofia Facchi³

¹Aziende Socio Sanitarie Territoriale dei Sette Laghi, Varese, VA, Italy.

Cancer prevention research (Philadelphia, Pa.)

|April 17, 2025

概括

卵巢癌中的同源重组修复 (HRR) 缺陷预测PARP抑制剂反应. 这项研究评估了三个HRD测试,发现它们识别了符合条件的患者,并与遗传癌症风险的遗传咨询联系在一起.

科学领域:

在瘤学瘤学.
遗传学是一个遗传学.
分子生物学分子生物学

背景情况:

大约50%的高级卵巢癌在同类重组修复 (HRR) 基因中存在遗传/表观遗传变异,主要是BRCA1/2.2.
通过基因组不稳定性检测到的HRR缺陷,使卵巢癌对PARP抑制剂产生敏感性.
商业同源的DNA修复缺陷 (HRD) 测试,结合瘤BRCA测试和基因组不稳定性得分,临床上可用.

研究的目的:

为了评估三个不同的HRD测试的性能.
改善卵巢癌治疗管理和预防策略.
为了将HRD状态与治疗资格和遗传癌症风险相关联.

主要方法:

从50名高度卵巢癌患者的瘤样本中,分析了BRCA状态,基因组不稳定性和BRCA1促进物甲基化.
检测出BRCA变异或基因组不稳定的患者进行了生殖线检测.
用三种不同的商业评估来评估人力资源发展地位.

主要成果:

在54%的病例中观察到积极的HRD状态.
在41%的基因组不稳定的患者中发现了致病性BRCA变异.
在20%的HRD阳性,BRCA1/2-变异-阴性癌症中检测到BRCA1促进剂高甲基化.
在26名女性中,有10名女性携带了生殖系HRR变异.
在大多数情况下,HRD状态决定了PARP抑制剂的适用性.

结论:

对于指导卵巢癌中PARP抑制剂治疗,HRD测试至关重要.
基因组不稳定性评估有助于识别潜在的遗传性卵巢癌.
将HRD测试与遗传咨询途径相结合,对于管理高风险个体和优化卵巢癌护理至关重要.

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing

Published on: September 15, 2023

相关概念视频

Hazard Ratio

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...